Anthony Cataldo
Equibles does not estimate personal net worth.
Get an email with a short summary when GT Biopharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get GTBP alertsAbout Anthony Cataldo
Anthony Cataldo is recorded as CEO at GT Biopharma, Inc. (GTBP). The proxy statement of GT Biopharma, Inc. reports total compensation of $10,494,677 for Anthony Cataldo in fiscal 2021, including a base salary of $479,936. Disclosed compensation is on record for 2 fiscal years. GT Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at GT Biopharma, Inc. includes Dr. Gregory Berk (CEO), Michael Breen (CEO and Board Member), Bruce Wendel (Chairman) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at GT Biopharma, Inc.
- Dr. Gregory Berk CEO
- Michael Breen CEO, Board Member
- Bruce Wendel Chairman
- Alan L. Urban CFO, Board Member
- Alan Urban CFO
- Dr. Gavin Choy CFO
- Michael Handelman CFO
- Andrew Ritter Board Member
- Charles J. Casamento Board Member
- David C. Mun-Gavin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | GT Biopharma, Inc. (GTBP) | Former Chief Executive Officer | $479,936 | $10,494,677 |
| 2020 | GT Biopharma, Inc. (GTBP) | Former Chief Executive Officer | $323,571 | $428,817 |
Recent activity
No call appearances or filed executive changes recorded yet.